Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_assertion type Assertion NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_head.
- NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_assertion description "[The combined inhibition of EGFR and MET receptor could represent a strategy for preventing and/or overcoming cetuximab resistance in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_provenance.
- NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_assertion evidence source_evidence_literature NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_provenance.
- NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_assertion SIO_000772 24122793 NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_provenance.
- NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_assertion wasDerivedFrom befree-20150227 NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_provenance.
- NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_assertion wasGeneratedBy ECO_0000203 NP554522.RAy3RIbZsVbo9AT40jxDlSL2Kf_UeN3dwu3xa6n4TboSk130_provenance.